NMOSD Features

Gamida Cell warehouse team

Omidubicel Shows Promise as Replacement for Umbilical Cord Blood in Stem Cell Transplants

Gamida Cell is gearing up to begin sales of omidubicel from Israel to US hospitals for use in stem cell transplants, pending FDA approval of the therapy.

Next post in Features